期刊
FUTURE MICROBIOLOGY
卷 13, 期 5, 页码 525-533出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fmb-2016-0171
关键词
antimicrobial activity; BAG-S53P4; bioactive glass; bone and joint infections; bone graft; Enterobacteriaceae; gentamicin; MRSA; MRSE; vancomycin
类别
资金
- BonAlive Biomaterials Ltd (Turku, Finland)
Aim: To evaluate the suitability of bioactive glass (BAG)-S53P4 as a bone-graft extender for large bony defect filling in bone and joint infection. Materials & methods: Antimicrobial activity of BAG-S53P4 against clinically relevant strains isolated from bone and joint infections was evaluated by means of time-kill curves in presence of bone graft. Furthermore, the susceptibility to BAG of strains resistant to vancomycin and gentamicin was assessed. Results: Though attenuated, BAG maintains a good in vitro antimicrobial activity in presence of human body fluids and tissues contained in bone graft, with the exception of Enterococcus faecalis. Conclusion: BAG-S53P4 is a suitable bone substitute that can be used as an extender with autologous bone graft to promote better fusion and healing.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据